Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cancer

Topics

Medicine

Cancer Oncology

Internal Medicine

Surgery

Otorhinolaryngology

Show all topics

DOI

10.1002/1097-0142(19850301)55:5<1123::aid-cncr2820550530>3.0.co;2-8